Nearly all biotech stock investors get impressed with similar articles and publications till the trials fail or get delayed. They always think that they have science that will change the world. They think their company will become next pharmacyclics or next regeron but in the end it turns out to be one of the dead cats on the side walk
News 
Market Data 
Discover 
